These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 36278447)

  • 1. Combined Immunotherapy and Targeted Therapies for Cancer Treatment: Recent Advances and Future Perspectives.
    Zhang Y; Li Y; Fu Q; Han Z; Wang D; Umar Shinge SA; Muluh TA; Lu X
    Curr Cancer Drug Targets; 2023; 23(4):251-264. PubMed ID: 36278447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
    Ascierto PA; Atkins M; Bifulco C; Botti G; Cochran A; Davies M; Demaria S; Dummer R; Ferrone S; Formenti S; Gajewski TF; Garbe C; Khleif S; Kiessling R; Lo R; Lorigan P; Arthur GM; Masucci G; Melero I; Mihm M; Palmieri G; Parmiani G; Puzanov I; Romero P; Schilling B; Seliger B; Stroncek D; Taube J; Tomei S; Zarour HM; Testori A; Wang E; Galon J; Ciliberto G; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2015 Nov; 13():374. PubMed ID: 26619946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives.
    Zhang Y; Liu C; Wu C; Song L
    Biomed Pharmacother; 2023 Mar; 159():114257. PubMed ID: 36689836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
    Ascierto PA; Agarwala SS; Ciliberto G; Demaria S; Dummer R; Duong CPM; Ferrone S; Formenti SC; Garbe C; Halaban R; Khleif S; Luke JJ; Mir LM; Overwijk WW; Postow M; Puzanov I; Sondel P; Taube JM; Thor Straten P; Stroncek DF; Wargo JA; Zarour H; Thurin M
    J Transl Med; 2017 Nov; 15(1):236. PubMed ID: 29145885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling cancer-immune responses to therapy.
    dePillis LG; Eladdadi A; Radunskaya AE
    J Pharmacokinet Pharmacodyn; 2014 Oct; 41(5):461-78. PubMed ID: 25281420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining immunotherapy and targeted therapies in cancer treatment.
    Vanneman M; Dranoff G
    Nat Rev Cancer; 2012 Mar; 12(4):237-51. PubMed ID: 22437869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cure in Advanced Renal Cell Cancer: Is It an Achievable Goal?
    Sabanathan D; Park JJ; Marquez M; Francisco L; Byrne N; Gurney H
    Oncologist; 2017 Dec; 22(12):1470-1477. PubMed ID: 29146617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia.
    Griggio V; Perutelli F; Salvetti C; Boccellato E; Boccadoro M; Vitale C; Coscia M
    Front Immunol; 2020; 11():594556. PubMed ID: 33312177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment.
    Pennock GK; Chow LQ
    Oncologist; 2015 Jul; 20(7):812-22. PubMed ID: 26069281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Immuno-Oncology.
    Jain KK
    Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
    Yang TK; Yu YF; Tsai CL; Li HJ; Yang PS; Huang KW; Cheng JC
    BMC Cancer; 2022 Oct; 22(1):1085. PubMed ID: 36271374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
    Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
    Front Immunol; 2018; 9():947. PubMed ID: 29770138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.
    de Pinho Pessoa FMC; Machado CB; da Silva EL; da Costa Pantoja L; Ribeiro RM; de Moraes MEA; de Moraes Filho MO; Montenegro RC; Khayat AS; Moreira-Nunes CA
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
    Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
    Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving synergistic combinations of targeted immunotherapies to combat cancer.
    Melero I; Berman DM; Aznar MA; Korman AJ; Pérez Gracia JL; Haanen J
    Nat Rev Cancer; 2015 Aug; 15(8):457-72. PubMed ID: 26205340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the discovery and development of melanoma drug therapies.
    Chanda M; Cohen MS
    Expert Opin Drug Discov; 2021 Nov; 16(11):1319-1347. PubMed ID: 34157926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.